Commercial development considerations for biotechnology-derived therapeutics

By Marafino B.   Pugsley M.  

Cardiovascular Toxicology, Vol. 3, Iss. 1, 2003-03 ,pp. : 5-12

Humana Press, Inc

Access to resources Recommend Favorite

Cardiovascular toxicity of particulate air pollution

By Kang Y.  

Cardiovascular Toxicology, Vol. 2, Iss. 4, 2002-12 ,pp. : 233-235

Humana Press, Inc

Access to resources Recommend Favorite

Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects

By  

Current Vascular Pharmacology, Vol. 1, Iss. 2, 2003-06 ,pp. : 135-156

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Toxicity With Highly Active Antiretroviral Therapy: Review of Clinical Studies

By Bozkurt Biykem  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 243-260

Humana Press, Inc

Access to resources Recommend Favorite

Cardiovascular Toxicity from the Perspective of Oxidative Stress, Electron Transfer, and Prevention by Antioxidants

By  

Current Vascular Pharmacology, Vol. 3, Iss. 2, 2005-04 ,pp. : 107-117

Bentham Science Publishers

Access to resources Recommend Favorite